BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17455665)

  • 1. [Antiviral resistance of influenza viruses].
    Saito R; Suzuki H
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():471-5. PubMed ID: 17455665
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en.
    Honda T; Kubo S; Masuda T; Arai M; Kobayashi Y; Yamashita M
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2938-40. PubMed ID: 19414262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral resistance in influenza viruses--implications for management and pandemic response.
    Hayden FG
    N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of oseltamivir phosphonate congeners as anti-influenza agents.
    Cheng TJ; Weinheimer S; Tarbet EB; Jan JT; Cheng YS; Shie JJ; Chen CL; Chen CA; Hsieh WC; Huang PW; Lin WH; Wang SY; Fang JM; Hu OY; Wong CH
    J Med Chem; 2012 Oct; 55(20):8657-70. PubMed ID: 23009169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
    Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivirals for influenza: historical perspectives and lessons learned.
    Hayden FG
    Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-resistant influenza viruses: an overview].
    Hatakeyama S
    Nihon Rinsho; 2010 Sep; 68(9):1671-8. PubMed ID: 20845746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors.
    Tolah AM; Azhar EI; Hashem AM
    Saudi Med J; 2016 Apr; 37(4):461-5. PubMed ID: 27052292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The origin of the genetic variability of influenza viruses].
    Salazar MI; López-Ortega O; León-Avila G; Ramírez-Gónzalez JE; Castro-Mussot ME
    Gac Med Mex; 2010; 146(3):199-206. PubMed ID: 20957816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral agents for influenza].
    Mitamura K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():401-6. PubMed ID: 17455653
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular docking, 3D-QSAR studies, and in silico ADME prediction of p-aminosalicylic acid derivatives as neuraminidase inhibitors.
    Zhang J; Shan Y; Pan X; Wang C; Xu W; He L
    Chem Biol Drug Des; 2011 Oct; 78(4):709-17. PubMed ID: 21752201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza--the case for combination therapy.
    Krystal MR; Meanwell NA
    Curr Opin Investig Drugs; 2009 Aug; 10(8):746-9. PubMed ID: 19649919
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
    Lackenby A; Democratis J; Siqueira MM; Zambon MC
    Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral agents for influenza].
    Mitamura K
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():798-803. PubMed ID: 12722319
    [No Abstract]   [Full Text] [Related]  

  • 15. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC; Wedde M; Birkner P; Schweiger B
    Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2017 Oct; 92(42):625-33. PubMed ID: 29052409
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
    Enserink M
    Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
    [No Abstract]   [Full Text] [Related]  

  • 19. Virology. Helping the resistance.
    Holmes EC
    Science; 2010 Jun; 328(5983):1243-4. PubMed ID: 20522766
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
    Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
    Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.